Cite
Androgen deprivation therapy in prostate cancer: are rising concerns leading to falling use?
MLA
George Tomlinson, et al. “Androgen Deprivation Therapy in Prostate Cancer: Are Rising Concerns Leading to Falling Use?” BJU International, vol. 108, Mar. 2011, pp. 1588–96. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........862a11f48242bf51bc54a645fc8c9032&authtype=sso&custid=ns315887.
APA
George Tomlinson, Murray Krahn, Karen E. Bremner, Jin Luo, Shabbir M.H. Alibhai, Gary Naglie, & Paul Ritvo. (2011). Androgen deprivation therapy in prostate cancer: are rising concerns leading to falling use? BJU International, 108, 1588–1596.
Chicago
George Tomlinson, Murray Krahn, Karen E. Bremner, Jin Luo, Shabbir M.H. Alibhai, Gary Naglie, and Paul Ritvo. 2011. “Androgen Deprivation Therapy in Prostate Cancer: Are Rising Concerns Leading to Falling Use?” BJU International 108 (March): 1588–96. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........862a11f48242bf51bc54a645fc8c9032&authtype=sso&custid=ns315887.